Skip to main content
HR 6092 116th Congress House Armed Forces and National Security Cancer Congressional oversight Government information and archives Health care coverage and access Health information and medical records Intergovernmental relations Medical research Medical tests and diagnostic methods Public-private cooperation Veterans' medical care

Veteran’s Prostate Cancer Treatment and Research Act

Introduced: March 5, 2020 Introduced by: Dunn, Neal P. Republican · Florida See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 12 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 23, 2020
Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
Sep 22, 2020
Motion to reconsider laid on the table Agreed to without objection.
Sep 22, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4684-4685)
Sep 22, 2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Sep 22, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 6092.
Sep 22, 2020
Considered under suspension of the rules. (consideration: CR H4682-4685)
Sep 22, 2020
Mr. Takano moved to suspend the rules and pass the bill, as amended.
Sep 17, 2020
Ordered to be Reported by Voice Vote.
Sep 17, 2020
Committee Consideration and Mark-up Session Held.
Sep 10, 2020
Committee Hearings Held.
Mar 5, 2020
Referred to the House Committee on Veterans' Affairs.
Mar 5, 2020
Introduced in House
 Plain-English summary Congressional Research Service

Veteran's Prostate Cancer Treatment and Research Act

This bill requires the Department of Veterans Affairs (VA) to implement programs and resources related to the diagnosis and treatment of prostate cancer.

Specifically, the bill requires the VA to establish in its National Surgery Office a national clinical pathway for all stages of prostate cancer that includes specified elements. A clinical pathway is a health care management tool designed around research and evidence-backed practices that provides direction for the clinical care and treatment of a specific episode of a condition or ailment.

The VA must publish the proposed clinical pathway in the Federal Register for public comment. Additionally, the bill requires the VA to publish the established clinical pathway on a public VA website and to update the clinical pathway at least annually.

Under the bill, the VA must submit (1) a plan to establish a comprehensive prostate cancer program, and (2) a plan that provides for continual funding for supporting prostate cancer research through the VA Office of Research and Development. The VA must also establish a program evaluation tool to learn best practices of multidisciplinary disease-based implementation.

Finally, the VA must establish a real-time, actionable, national prostate cancer registry that is accessible to clinicians and researchers.

What's happening now September 23, 2020

Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

 Committees of jurisdiction 2
 Cosponsors 2
All 2 Republican 2